GlassScriptPhysician profile
Akash Nitin Patel
NPI 1588198477
$2,258.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $256 · 2023: $339 · 2024: $1,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,025 · Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,025.30 |
| Food and Beverage | $977.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $644.67 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Piedmont Plus Innovation | $624.56 | 2024 | |
| Arthrex, INC. | $540.03 | 2024 | Arthrex |
| Nalu Medical, INC. | $168.13 | 2022 | |
| Edwards Lifesciences Corporation | $144.07 | 2024 | Hemosphere |
| Averitas Pharma INC. | $29.49 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $28.91 | 2023 | Zilretta, Exparel, Iovera |
| Medtronic, INC. | $23.63 | 2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.37 | 2023 | Relistor |
| Radius Health, INC. | $18.15 | 2023 | Tymlos |
| Abbott Laboratories | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.